Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00924365 · ClinicalTrials.gov registry record
Natural History Study of HIV Acquired in Infancy or Childhood
A clinical trial of HIV Infections, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 54
- Enrollment target
- 1
- Study location
NCT00924365: Completed study of HIV Infections, sponsored by National Cancer Institute (NCI).
NCT00924365 is a study of HIV Infections that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 54 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00924365, a study of HIV Infections, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: * About 10,000 children in the United States have been living with HIV infection since birth. Little is known about the long-term effects of HIV infection and its treatment on the growth and development of these children. * Because of their disease, many children with HIV face additional difficulties with their health, well-being and development, such as success in school and peer relationships. Objectives: * To better understand how HIV infection and the medicines used to treat it affect the growth and development of children, adolescents and young adults who have been infected since birth or when they were very young. * To develop ways to improve the quality of life for these individuals. Eligibility: -HIV-infected patients who were followed by the pediatric HIV program in NCI as of December 2004, or an HIV-infected sibling of a participant. Design: * Periodic evaluation of pubertal development; bone mineralization; body composition and fat distribution; liver, kidney and heart status; and behavioral, cognitive and academic or vocational outcome of the study group. Evaluations include the following: * Physical examinations, including height and weight measurements and skin-fold thickness testing to measure body fat. * Review of medical records and family history. * Blood and urine tests, including pregnancy test in females who can bear children. * DEXA scans (X-ray test to measure bone strength and how much fat, muscle and bone is in the body). * Neuropsychological testing, including evaluation of language, thinking and problem-solving abilities. * Magnetic resonance imaging (MRI): Test using a magnetic field and radio waves to examine brain structure and function. * Oral glucose tolerance test: Blood sampling before and one time after the subject drinks a sugary solution to measure the body's ability to use sugar
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2007-02-01 |
| Est. Completion | 2014-04-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00924365
The ClinicalTrials.gov registry entry for NCT00924365 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (88% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00924365 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00924365 about?
NCT00924365 is a clinical study titled "Natural History Study of HIV Acquired in Infancy or Childhood". Background: * About 10,000 children in the United States have been living with HIV infection since birth. Little is known about the long-term effects of HIV infection and its treatment on the growth and development of these children. * Because of their disease, many children with HIV face additiona...
What is the current status of trial NCT00924365?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2007-02-01. Estimated completion is 2014-04-22.
What conditions does trial NCT00924365 study?
This clinical trial studies the following conditions: HIV Infections.
Who is sponsoring clinical trial NCT00924365?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00924365 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.